Citrate synthase [CS, ATP-citrate synthase (ACLY)] acts synergistically to regulate the conversion balance of citrate to oxaloacetate and acetyl-CoA (Marin-Garcia et al., 1998; Potapova et al., 2000), which were also significantly reduced in multiple brain regions of AD. This evidence concerns the gene ACLY and Alzheimer disease.